This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Jun;22(6):1462-1463.

doi: 10.1093/annonc/mdr257. Epub 2011 Apr 27.

Different hepatitis B carrier categories need different management strategies in case of immunosuppressive chemotherapeutic regimens

E Gigante¹, I Deli², S Gallina², E De Santis², G Delle Fave², M Marignani²

Affiliations

Affiliations

¹ Digestive and Liver Disease Department, Second Medical Faculty, University "Sapienza", Azienda Ospedaliera S. Andrea, Rome, Italy. Electronic address: whitegiant@hotmail.it.
² Digestive and Liver Disease Department, Second Medical Faculty, University "Sapienza", Azienda Ospedaliera S. Andrea, Rome, Italy.

PMID: 21525405
DOI: 10.1093/annonc/mdr257

Free article

Comment

Different hepatitis B carrier categories need different management strategies in case of immunosuppressive chemotherapeutic regimens

E Gigante et al. Ann Oncol. 2011 Jun.

Free article

. 2011 Jun;22(6):1462-1463.

doi: 10.1093/annonc/mdr257. Epub 2011 Apr 27.

Authors

E Gigante¹, I Deli², S Gallina², E De Santis², G Delle Fave², M Marignani²

Affiliations

¹ Digestive and Liver Disease Department, Second Medical Faculty, University "Sapienza", Azienda Ospedaliera S. Andrea, Rome, Italy. Electronic address: whitegiant@hotmail.it.
² Digestive and Liver Disease Department, Second Medical Faculty, University "Sapienza", Azienda Ospedaliera S. Andrea, Rome, Italy.

PMID: 21525405
DOI: 10.1093/annonc/mdr257

No abstract available

PubMed Disclaimer

Comment on

Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports.
Evens AM, Jovanovic BD, Su YC, Raisch DW, Ganger D, Belknap SM, Dai MS, Chiu BC, Fintel B, Cheng Y, Chuang SS, Lee MY, Chen TY, Lin SF, Kuo CY. Evens AM, et al. Ann Oncol. 2011 May;22(5):1170-1180. doi: 10.1093/annonc/mdq583. Epub 2010 Nov 29. Ann Oncol. 2011. PMID: 21115603 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information